PsychoGenics

PsychoGenics is a preclinical contract research organization (CRO) specializing in central nervous system (CNS) drug discovery and development. They offer a wide range of services, including behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis, all supported by a diverse portfolio of validated disease models. PsychoGenics is known for its high-quality, cutting-edge translational approach to research and its customized solutions to support clients in quantifying the efficacy of their treatments before they move into the clinic.

PsychoGenics boasts a strong team of highly trained experts, including Ph.D. scientists and veteran executives. The company emphasizes teamwork, diversity, and innovation, providing a supportive environment for employee growth and development. Their commitment to corporate social responsibility extends to collaborations with academia, government institutions, and foundations to discover new treatments for neurological and mental health disorders. PsychoGenics' innovative Cube Technologies, including SmartCube®, NeuroCube®, eCube®, and PhenoCube®, leverage artificial intelligence (AI) to revolutionize neuropsychiatric drug discovery.

PsychoGenics values its employees and offers a comprehensive benefits package designed to attract and retain top talent. Employees enjoy competitive compensation, a variety of health insurance plans, a 401(k) plan with company match, paid time off, and opportunities for professional development. They also offer a supportive and collaborative work environment that fosters growth and rewards hard work and creativity.

PsychoGenics is a preclinical contract research organization (CRO) specializing in central nervous system (CNS) and orphan disorders. Their mission is to accelerate the discovery of new and improved treatments for these debilitating conditions by providing the highest quality validated disease models and comprehensive preclinical capabilities. They aim to reduce attrition rates in clinical development by providing data-rich insights that enable informed decision-making and propel breakthroughs in neurological and mental health research.

PsychoGenics cultivates a collaborative, diverse, and passionate work environment that values teamwork, innovation, and professional growth. They emphasize an entrepreneurial spirit, where employees are empowered to take initiative and contribute to the company's mission of discovering breakthrough CNS therapies. Their focus on fostering a positive and inclusive culture is evident in their commitment to diversity, employee rewards, and corporate social responsibility, creating a workplace where individuals can thrive and make a meaningful difference in the lives of patients.

PsychoGenics is committed to fostering a diverse and inclusive workplace. The company believes in embracing talent from all backgrounds and encouraging diverse perspectives to create a climate of respect and trust where collaboration can thrive. PsychoGenics prioritizes equal-employment principles, recognizing the value of loyal employees and striving to reward and retain them while also attracting and developing new talent to meet business objectives. The company is committed to minimizing the environmental effect of its operations through the promotion of environmental awareness, use of online communications and teleconferencing tools, and running an energy-efficient building. PsychoGenics also practices sustainable waste management and identifies and assesses its environmental impacts on an ongoing basis.